The impact of Chilean health reform in the management and mortality of ST elevation myocardial infarction (STEMI) in Chilean hospitals;Impacto del plan AUGE en el tratamiento de pacientes con infarto agudo al miocardio con supradesnivel ST, en hospitales chilenos

Revista Medica de Chile

Volumn 136, Issue 10, 2008, Pages 1231-1239

  Nazzal, Carolina N ^a,g   Campos, Pabla T ^b   Corbalán, Ramón H ^c   Lanas, Fernando Z ^d   Bartolucci, Jorge J ^e   Sanhueza, Patricio C ^f   Cavada, Gabriel C ^a,g   Prieto, Juan Carlos D ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Hospital de Urgencia Asistencia Pública Doctor Alejandro del Rio   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d UNIVERSIDAD DE LA FRONTERA   (Chile)

^e UNIVERSIDAD DE LOS ANDES   (Chile)

^f HOSPITAL SAN JUAN DE DIOS   (Chile)

^g Magíster en Salud Pública ^*  (Argentina)

Author keywords

Myocardial infarction; Myocardial reperfusion; Thrombolytic therapy

Indexed keywords

ARTICLE; CHILE; CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEART INFARCTION; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; STANDARD; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UTILIZATION REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHILE; DELIVERY OF HEALTH CARE; EMERGENCY MEDICAL SERVICES; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH PLAN IMPLEMENTATION; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 64249147701     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Objetivos sanitarios para la década 2000-2010. Disponible en: http://epi.minsal.cl/epi/html/elvigia/vigia15.pdf
2. Primer régimen de Garantías Explícitas en Salud. Disponible en: http://www.redsalud.gov.cl/archivos/guiasges/primerregimengarantias.pdf
3. Grupo GEMI : ¿Es posible para la cardiología chilena realizar estudios multicéntricos? Grupo de estudio multi-céntrico del infarto (GEMI). Farmacoepidemiología del infarto agudo del miocardio en centros hospitalarios chilenos. Rev Chil Cardiol 1993; 12: 153-60.
4. Corbalán R, Prieto JC, Chávez E, Nazzal C, Cumsille F, Krucoff M. Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis. Am Heart J 1999; 138: 533-9.
5. Corbalán R, Nazzal C, Prieto JC, Chávez E, Lanas F, Lamich R et al . Reducción de la mortalidad por infarto del miocardio en hospitales chilenos. Rev Méd Chile 2002; 130: 368-78.
6. Aros F, Loma-Osorio A, Bosch J, González J, López L, Marrugat J et al . Manejo del infarto de miocardio en España (1995-99). Datos del registro de infartos de la Sección de Cardiopatía Isquémica y Unidades Coronarias (RISCI) de la Sociedad Española de Cardiología. Rev Esp Cardiol 2001; 54: 1033-40.
7. Hammar N, Alfredsson L, Rosen M, Spetz C, Kahan T, Ysberg A. A National record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001; 30: S30-S34.
8. Ford E, Ajani U, Croft J, Critchley J, Labarthe D, Kottke TE et al . Explaininig the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388-98.
9. Prieto JC, Sanhueza C, Martínez N, Nazzal C, Corbalán R, Cavada G et al . Mortalidad intrahospitalaria en hombres y mujeres según terapias de reperfusión en infarto agudo del miocardio con supradesnivel del ST. Rev Méd Chile 2008; 136: 143-50.
10. Nazzal C, Bartolucci J, Lanas F, Prieto JC, Corbalán R, Cumsille F. Mortalidad por infarto agudo al miocardio en tres periodos del Registro GEMI : diferencias entre hombres y mujeres. Rev Chil Cardiol 2003; 72: 172.
11. Hanratty B, Lawlor DA, Robinson MB, Sapsford RJ, Greenwood D, Hall A. Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study. Epidemiol Community Health 2000; 54: 912-6.
12. Campos P, Nazzal C, Prieto JC, Sanhueza P, Venegas J. Cumplimiento de las guías clínicas en pacientes de alto riesgo del Registro GEMI . Rev Chil Cardiol 2006; 25: 13.
13. Carrabba N, Santoro G, Balzi D, Barchielli A, Mar-chionni N, FabianI P et al . In-hospital management and outcome in women acute myocardial infarction (data from the AMI-Florence Registry). Am J Cardiol 2004; 94: 1118-23.
14. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative over-view of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343: 311-22.
15. Barbagelata A, Perna E, Clemmensen P, Uretsky BF, Canella JP, Califf RM et al . Time to reperfusion in acute myocardial infarction. It is time to reduce it! J Electrocardiol 2007; 40: 257-64.
16. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C et al Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-47.
17. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771-5.
18. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P et al. Comparison of Angioplasty and Prehospital Thrombolysis in acute Myocardial Infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003; 108: 2851-6.
19. Antman EM, Anbe DT, Armstrong P, Bates E, Green L, Hand M et al . ACC/AHA guidelines for the management of patients with ST -elevation myocardial infarction- executive summary. A report of the American College of cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2004; 44: 671-719.
20. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA et al Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24: 28-66.
21. st Ed. Santiago: Minsal, 2005.
22. Robles C, Zepeda S, Corbalán R, Rodríguez JA, Kunstmann F, Castro P et al . Complicaciones del tratamiento trombolítico en paciente con infarto del miocardio. Rev Chil Cardiol 1995; 14: 216-21.
23. Fernández-A viles F, Alonso JJ, Castro-Beiras A, Vázquez N, Blanco J, Alonso-Briales J et al . GRACIA (Grupo de Análisis de la Cardiopatía Isquémica Aguda) Group. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomized controlled trial. Lancet 2004; 364: 1045-53.
24. Banerjee P, Clark AL, Norell MS. Repeat thrombolysis for acute myocardial infarction. Int J Cardiol 2005; 102: 515-9.
25. Sarullo FM, Americo L, Di Pasquale P, Castello A, Mauri F. Efficacy of rescue thrombolysis in patients with acute myocardial infarction: preliminary findings. Cardiovasc Drugs Ther 2000; 14: 83-9.
26. Campos P, Nazzal C, Chávez E. Infarto con ST trombolizado en el Hospital de Urgencia de la Asistencia Pública ¿coronariografía de rutina? implicancias en la sobrevida, Hospital de Urgencia de la Asistencia Pública y Grupo GEMI Sociedad Chilena de Cardiología y Cirugía Cardiovascular. Rev Chil Cardiol 2006; 25: 117.
27. Prieto JC, Corbalán R, Chávez E, Lanas F, Nazzal C, Cumsille F. Cambios en la prescripción de medicamentos y reducción de la mortalidad intrahospitalaria en pacientes con infarto agudo al miocardio. Investigación Cardiovascular 2003; 2: 99-108.
28. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB et al . Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007; 297: 1892-900.